Back to today’s briefing

Story perspectives

Revolutionary Cancer Treatment Boosts Immune Response, Personalizes Therapy

5/20/2025

24 3

Summary

Story summary

Bexmarilimab, a groundbreaking cancer treatment from Finland, empowers macrophages to fight tumors, especially in areas where the immune response is weak. It also stimulates B cells in nearby healthy tissue. By pinpointing a specific gene signature, researchers aim to refine patient selection, paving the way for personalized immunotherapies and broader access to this innovative treatment.

1 of 1

Story summary

Bexmarilimab, a groundbreaking cancer treatment from Finland, empowers macrophages to fight tumors, especially in areas where the immune response is weak. It also stimulates B cells in nearby healthy tissue. By pinpointing a specific gene signature, researchers aim to refine patient selection, paving the way for personalized immunotherapies and broader access to this innovative treatment.